Paul C. Gordon, M.D.’s research interests include evaluating therapies and novel devices for coronary and structural heart disease. His current research focuses on transcatheter aortic valves with projects such as Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) and Edoxaban versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation-in Atrial Fibrillation. His other research project is on Physiologic Assessment of Coronary Stenosis Following PCI (DEFINE PCI). 

Studies currently enrolling

• ENVISAGE - Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation – In Atrial Fibrillation.
• VIVIO - Assessment of the Vivio System as an Aid in the Identification of Heart Sounds Associated with Severe Aortic Stenosis
• TAVR UNLOAD - Transcatheter Aortic Valve Replacement to Unload the Left Ventricle in Patients with Advenced Heart Failure: A Randomized (TAVR UNLOAD)
• TROPONIN I - Troponin I Specimen Collection. The primary objective of this protocol is to collect paired serum and lithium heparin plasma samples with different Troponin I (TnI) levels to conduct a sample stability study.

2004, 2009 Dean's Teaching Award, Brown University Alpert Medical School

2017 The Raymon S. Riley, MD, Memorial Teaching Award, nominated by Brown Cardiovascular Fellows

2019 Dean's Excellence in Teaching Award, Clinical Faculty Advisory Committee Honoree, Brown University Alpert Medical School

Rhode Island Hospital

The Miriam Hospital

American College of Cardiology Fellow, 1990 - Present

Society for Cardiac Angiography and Interventions, Associate Fellow, 1993 - Present